References
- SiegelRMaJZouZJemalACancer statistics, 2014CA Cancer J Clin201464192924399786
- TorreLABrayFSiegelRLFerlayJLortet-TieulentJJemalAGlobal cancer statistics, 2012CA Cancer J Clin20156528710825651787
- EttingerDSWoodDEAkerleyWNon-small cell lung cancer, version 6. 2015J Natl Compr Canc Netw201513551552425964637
- NuciforaGLaricchia-RobbioLSenyukVEVI1 and hematopoietic disorders: history and perspectivesGene200636811116314052
- HellerGRommerASteinleitnerKEVI1 promotes tumor growth via transcriptional repression of MS4A3J Hematol Oncol201582825886616
- WangHSchaeferTKonantzMProminent oncogenic roles of EVI1 in breast carcinomaCancer Res2017772148216028209621
- QueisserAHagedornSWangHEcotropic viral integration site 1, a novel oncogene in prostate cancerOncogene2017361573158427617580
- SatoTGoyamaSKataokaKEvi1 defines leukemia-initiating capacity and tyrosine kinase inhibitor resistance in chronic myeloid leukemiaOncogene201433425028503824747972
- HouAZhaoLZhaoFExpression of MECOM is associated with unfavorable prognosis in glioblastoma multiformeOnco Targets Ther2016931532026834490
- KangJUKooSHKwonKCParkJWKimJMIdentification of novel candidate target genes, including EPHB3, MASP1 and SST at 3q26.2-q29 in squamous cell carcinoma of the lungBMC Cancer2009923719607727
- HirschFRSudaKWiensJBunnPAJrNew and emerging targeted treatments in advanced non-small-cell lung cancerLancet2016388100481012102427598681
- XuYFYangXQLuXFFibroblast growth factor receptor 4 promotes progression and correlates to poor prognosis in cholangiocarcinomaBiochem Biophys Res Commun20144461546024565842
- XuYYangXLiZSprouty2 correlates with favorable prognosis of gastric adenocarcinoma via suppressing FGFR2-induced ERK phosphorylation and cancer progressionOncotarget201784888490028002800
- XuYFGeFJHanBHigh-mobility group box 1 expression and lymph node metastasis in intrahepatic cholangiocarcinomaWorld J Gastroenterol201521113256326525805932
- LiuHZhangQLiKPrognostic significance of USP33 in advanced colorectal cancer patients: new insights into β-arrestin-dependent ERK signalingOncotarget20167812238124027835898
- LiuHXuYZhangQCorrelations between TBL1XR1 and recurrence of colorectal cancerSci Rep201774427528295012
- FenouilleNBassilCFBen-SahraIThe creatine kinase pathway is a metabolic vulnerability in EVI1-positive acute myeloid leukemiaNat med Epub2017213
- YasuiKKonishiCGenYEVI1, a target gene for amplification at 3q26, antagonizes transforming growth factor-β-mediated growth inhibition in hepatocellular carcinomaCancer Sci2015106792993725959919
- NanjundanMNakayamaYChengKWAmplification of MDS1/EVI1 and EVI1, located in the 3q26.2 amplicon, is associated with favorable patient prognosis in ovarian cancerCancer Res20076773074308417409414
- HinaiAAValkPJReview: Aberrant EVI1 expression in acute myeloid leukaemiaBr J Haematol2016172687087826729571
- WieserRThe oncogene and developmental regulator EVI1: expression, biochemical properties, and biological functionsGene2007396234635717507183